PAXIL

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Japan, Mexico, South Africa, Turkey.

Active ingredients

The drug PAXIL contains one active pharmaceutical ingredient (API):

1	Paroxetine UNII X2ELS050D8 - PAROXETINE HYDROCHLORIDE
	Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones.
	Read more about Paroxetine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PAXIL Film‑coated tablet / Oral suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB05	Paroxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510609902112214, 510609904115210, 510617060056803, 510617060056903, 510617060057003
CA	Health Products and Food Branch	01940473, 01940481, 02027887, 02248503, 02248504
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.041-04-03, 29300-07-10, 29367-09-10, 5847-MEE-0121
JP	医薬品医療機器総合機構	1179041F1025, 1179041F2021, 1179041F3028, 1179041G1020, 1179041G2027, 1179041G3023
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	008M93, 511M2004
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522092802, 8699522096947
US	FDA, National Drug Code	60505-0402, 60505-3663, 60505-3664, 60505-3665, 60505-3666, 60505-3668, 60505-3669, 60505-3670, 60505-4377, 60505-4378, 60505-4379, 60505-4517, 60505-4518, 60505-4519, 60505-4520, 70518-2500, 70518-2636, 71335-0572
ZA	Health Products Regulatory Authority	A39/1.2/0078